Patients with kidney disease who take calcium-based phosphate binders to lower their phosphorus levels may be at a 22% higher risk of death that those who take other non-calcium based treatments.

A new study by Canadian researchers has found a reduction in the risk of death among patients who took the non-calcium based treatments sevelamer and lanthanum.

Continue Reading

John Schieszer has the story in today’s Medical Minute.